Published Abstracts (Journals)

  1. Nargund VH, Parapia L, Flannigan GM, Stewart PAh, Crawford SM. Effect of commonly
    used intravesical drugs on the EGFR expression of established TCC cell lines. Journal of Oncology 1994; 5: 6
  2. Nargund VH, Yoshida K, Smith JC, Fellows GJ, Cranston DW, Tarin D. Telomerase activity in
    transitional cell carcinoma; its implications for non-invasive detection of bladder cancer.
    British Journal of Urology 1996; 77(Suppl): 10-11
  3. Nargund VH, Noble JG, Cranston D, Fellows GJ. P148: Haematuria: A long-term problem
    after prostatectomy. British Journal of Urology 1998; 81(4) suppl: 50
  4. Fenely MR, Jan H, Granowska M, Mather SJ, Ellison D, Oliver RTD, Badenoch DF,
    Chinegwundoh FC, Nargund VH, Paris AMI, Britton KE. P93: Prostate cancer imaging with
    Indium-111 labelled monoclonal antibody to prostate membrane specific antigen (PMSA).
    British Journal of Urology 1998; 81: 30
  5. Nargund VH, Oliver RTD, Baithun S, Ong J, Sohaib A, Reznek R, Badenoch DF, Paris AMI.
    P23: Chemotherapy ┬▒Partial orchidectomy for testis conservation in patients with germ cell
    cancer (GCC). British Journal of Urology 1998; 81(4): 4
  6. Otite U, Dacie J, Chan L, Mahesh Kumar, Nargund VH. Percutaneous antegrade stenting is
    still an effective treatment for malignant ureteric strictures. European Urology 2000; 37; 66
  7. Otite U, Nambirajan T, Chan L, Webb JA, Hendry WF, Nargund VH. Testicular
    microlithiasis: A benign condition with a malignant association or simply a premalignant
    condition? Journal of Urology 2000; 163 (Suppl); 315
  8. Kumar M, Martin J, Nargund VH, Burney D. Expression of TGF receptors type1 and type 2
    in superficial TCC bladder. British Journal of Cancer 2000; 83
  9. Kumar M, Martin J, Nargund VH, Burney D. Cyclooxygenase2 expression in superficial TCC
    of bladder. British Journal of Cancer 2000; 83
  10. Kumar M, Martin J, Otite U, Gordon S, Nargund V, Burney D. Role of Cyclooxygenase 2 in
    superficial TCC bladder. European Urology 2001; 39: 116
  11. Britton KE, Gordon SJ, Canizales A, Otite U, Mather SJ, Ellison D, Elnaas S, Jan H, Bander
    NH, Nargund VH. Prostate cancer imaging with 99Tcm-J591 monoclonal antibody against
    prostate specific membrane antigen. Nuclear Medicine Communications 2001; 22: 454
  12. Lucas M, Stephenson T and Nargund VH. Tamsulosin in the management of patients in
    acute urinary retention due to BPH. European Journal of Urology 2002; 1:106
  13. Gordon S, Otite U, Stewart E and Nargund V. Evaluation of 5% lignocaine ointment on
    patient tolerance to TRUS- prostatic biopsy. European Journal of Urology 2002; 1: 118
  14. Nargund VH, Lucas M, Stephenson T. Tamsulosin effectively reduces the need for
    recatheterisation in elderly male patients with a subsequent episode of acute urinary
    retention due to benign prostatic hyperplasia. British Journal of Urology International 2002;
    90(2):76-77
  15. Lucas M, Stephenson T, Nargund V. Tamsulosin reduces the need for recatheterisation in
    elderly male patients with a subsequent episode of acute urinary retention due to benign
    prostatic hyperplasia. Journal of Urology 2002; 167: 1047
  16. Otite U, Iles R, Jacoby E, Baithun S, Chinegwundoh F, Nargund V. Evaluation of serum and
    urinary human chorionic gonadotrophin beta and beta core fragment detected by
    immunoassay in the clinical management of prostate cancer. BJU International 2002; 90: 245
  17. Enver MK, Otite U, Iles R, Chinegwundoh FI, Persad R, Nargund VH. Elevated serum levels
    of the aminoterminal propeptide of type I procollagen (P1NP) are associated with a poor
    prognosis in metastatic prostate cancer. Prostate Cancer and Prosattic diseases. 2003: 6: 90-
    1
  18. Bhardwa J, Maheshkumar P, Berney D, Martin JE, Nargund VH. Gene expression profiling
    of superficial bladder cancer using DNA chip technology. British Journal of Urology Int 2003;
    92: 831
  19. Bharadwa J, Oliver RTD, Nargund VH, Berney D. Reduction in testicular germ cell cancer
    size with increasing awareness. British Journal of Cancer 2003; 88: S64
  20. Bharadwa J, Kumar M, Berney D, Martin J, Nargund VH. Genetic profiling of superficial
    bladder cancer. British Journal of Cancer 2003; 88: S50
  21. Bhardwa J, Sangtani BK and Nargund VH. A single centre audit of bladder cancer. British
    Journal of Cancer 2003; 88: S72
  22. Gordon S J, Campbell S, Bhardwa J, Nargund V H. Testicular arterial blood flow in normal
    and azoospermic men. British Journal of Urology International 2003; 91(2): 87
  23. Carroll M J, El-Megadmi H, Elnaas S, Chilab S, Nargund V, Britton KE (P18). Prostate
    cancer: combined Prostascint SPET/CT/blood pool imaging. Nuclear Medicine
    Communications 2003; 24: 473
  24. Otite U, Iles R, Jacoby E, Baithun S, Chinegwundoh F and Nargund VH. Evaluation of
    serum and urinary human chorionic gonadotrophin beta and beta core fragment detected
    by immunoassay in the clinical management of prostate cancer. British Journal of Urology
    International 2002; 90: 245
  25. Gordon S J, Campbell SC, Nargund VH. Testicular arterial blood flow as a marker of
    spermatogenesis. Journal of Urology 2004; 171 (4); 413
  26. Nargund VH, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M, Britton K.
    Imaging with radiolabelled monoclonal antibody specific for extracellar domain of prostate
    specific membrane antigen (PSMA) in staging prostate carcinoma for patients undergoing
    radical prostatectomy. Journal of Urology 2004; 171(4): 518 (No.1963)
  27. Bhardwa J, M,Berney D, Baithun S, Nargund V H, Oliver R T D. Reduction in the size of
    testicular germ cell tumours 1960-2003. British Journal of Urology (Suppl 4) 2004;93:19
  28. Kumar P, Bhardwa J, Kapoor S, Nargund V H. Treatment of anastomotic strictures
    following radical prostatectomy: An alternative approach using balloon dilatation. British
    Journal of Urology International 2004; 94 (Suppl.2): 210 (UP-8.21)
  29. Kumar P, Nargund V H. Samual Pepys: A patient. British Journal of Urology International
    2004; 94 (Suppl 2) : 301 (UP-19.06)
  30. Brennen N, Ghani K, Nargund V H. Changes: A survey of BAUS members on modernising
    Urology. British Journal of Urology International 2006; 97 (Suppl 3): 2 (015)
  31. Kumar P, Baithun S I, Oliver RTD, Nargund V. Angiogenesis and Lymphangiogenesis in
    testicular germ cell tumours (TGCT). British Journal of Urology International 2006; 97 (Suppl
    3): 13 (053)
  32. Bose PS, Kumar P, Nargund V, Pati J. Non-attendance in outpatients: causes and
    remedies. British Journal of Urology International 2006; 97 (Suppl 3): 69 (P065)